Fact CheckerSign in

NCT06805370Completed

Additional Mailed FIT Kits

Randomized Trial of Additional Mailed FIT Kits

Source: ClinicalTrials.gov · Last updated 5 Jun 2025

Brief summary (registry, in English)

This study aims to assess whether sending patients in a county health care system additional FIT Kits can increase the FIT Kit return rate enough to warrant the extra cost. To do this, the health system mailed a random subset of patients ages 60 to 75 a FIT Kit in November 2024 in addition to sending patients an annual FIT Kit mailing. This work analyzes the return rate of mailed FIT Kits within 60-days of the November mailing.

Status (registry)
Completed
Study type
Interventional
Enrollment
1700 (actual)
First submitted
15 Jan 2025
Start date
1 Nov 2024
Primary completion date
28 Feb 2025
Lead sponsor
University of Southern California
NCT number
NCT06805370

What you commit to

  • Study type: Interventional
  • Participants enrolled: 1700
  • From 1 Nov 2024 to the primary completion date, 28 Feb 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Not due for colorectal cancer screening;

Age

  • Under age 60 or over age 74;

Other

  • Incarcerated;
  • Sent a FIT Kit in the past 3-months.

Who the study is looking for

  • Age 60-74
  • Due for colorectal cancer screening;
  • Not sent a FIT Kit in the past 3-months;
  • Previously successfully returned a FIT Kit.

Age in the registry: 60 years to 74 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Contra Costa Health
Coordinator of this site? Confirm its status
MartinezUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.